Attenuation Imaging in Hepatic Steatosis

• Conditions: Hepatic Steatosis; Obesity, Childhood; Ultrasonography

• Registration Number: NCT05302258
• Lead Sponsor: Hallym University Kangnam Sacred Heart Hospital

Brief Summary

For obese and normal-weight children, the investigators assess the diagnostic performance of attenuation imaging (ATI) in the detection of hepatic steatosis in children.

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-03
• Study First Submitted: 2022-03-18
• Study First Submitted QC: 2022-03-29
• Last Update Submitted: 2022-03-29
• Study First Posted: 2022-03-31
• Last Update Posted: 2022-03-31
• Study Start: 2022-04-14
• Primary Completion: 2022-12-14
• Study Completion: 2022-12-14

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• BMI of 85th percentile or less

Exclusion Criteria

• congenital anomaly including heart, intestine, kidney
• acute hepatitis
• congenital hepatic anomaly

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnostic performance of attenuation imaging	through study completion, an average of 1 year	The diagnostic performance of attenuation imaging in US in the detection of hepatic steatosis